Table 2.

Evaluation of the growth of patient MCL cells in SCID-hu or SCID mice

Number of cells inoculated (×106)Mouse typeInjection locationHuman β2M (ng/mL) at 3 wk from inoculationSuccess rate
0.5-5SCID-huBone*38.215/20
2-5SCID-huIV3.491/5
2-5SCIDIV00/5
  • * Direct injection into human fetal bone cavity.

  • Intravenous injection via mouse tail vein. Data of each group are pooled from cells of patients 2 to 6.